NasdaqGS - Nasdaq Real Time Price USD
Accolade, Inc. (ACCD)
At close: November 4 at 4:00 PM EST
Pre-Market: 8:00 AM EST
Breakdown
TTM
2/29/2024
2/28/2023
2/28/2022
2/28/2021
Total Revenue
441,028.0000
414,292.0000
363,142.0000
310,021.0000
170,358.0000
Cost of Revenue
228,245.0000
222,232.0000
198,905.0000
169,019.0000
93,673.0000
Gross Profit
212,783.0000
192,060.0000
164,237.0000
141,002.0000
76,685.0000
Operating Expense
306,591.0000
306,513.0000
328,046.0000
312,143.0000
123,462.0000
Operating Income
-93,808.0000
-114,453.0000
-163,809.0000
-171,141.0000
-46,777.0000
Net Non Operating Interest Income Expense
6,701.0000
5,952.0000
255.0000
-2,905.0000
-3,724.0000
Other Income Expense
8,779.0000
9,931.0000
-299,720.0000
45,283.0000
-147.0000
Pretax Income
-78,328.0000
-98,570.0000
-463,274.0000
-128,763.0000
-50,648.0000
Tax Provision
1,769.0000
1,235.0000
-3,624.0000
-5,639.0000
4.0000
Net Income Common Stockholders
-80,097.0000
-99,805.0000
-459,650.0000
-123,124.0000
-50,652.0000
Diluted NI Available to Com Stockholders
-80,097.0000
-99,805.0000
-459,650.0000
-123,124.0000
-50,652.0000
Basic EPS
-1.02
-1.33
-6.45
-1.93
-1.72
Diluted EPS
-1.02
-1.33
-6.45
-1.93
-1.72
Basic Average Shares
77,291.3160
74,906.9380
71,279.8310
63,823.2700
29,370.5940
Diluted Average Shares
77,291.3160
74,906.9380
71,279.8310
63,823.2700
29,370.5940
Total Operating Income as Reported
-93,808.0000
-114,453.0000
-463,514.0000
-125,725.0000
-46,777.0000
Total Expenses
534,836.0000
528,745.0000
526,951.0000
481,162.0000
217,135.0000
Net Income from Continuing & Discontinued Operation
-80,097.0000
-99,805.0000
-459,650.0000
-123,124.0000
-50,652.0000
Normalized Income
-80,097.0000
-99,805.0000
-162,342.6400
-166,541.6960
-50,652.0000
Interest Income
--
--
255.0000
--
--
Interest Expense
--
--
--
2,905.0000
3,724.0000
Net Interest Income
6,701.0000
5,952.0000
255.0000
-2,905.0000
-3,724.0000
EBIT
-93,808.0000
-114,453.0000
-163,809.0000
-171,141.0000
-46,777.0000
EBITDA
-50,073.0000
-69,289.0000
-117,432.0000
-128,533.0000
-38,565.0000
Reconciled Cost of Revenue
228,245.0000
222,232.0000
198,905.0000
169,019.0000
93,673.0000
Reconciled Depreciation
43,735.0000
45,164.0000
46,377.0000
42,608.0000
8,212.0000
Net Income from Continuing Operation Net Minority Interest
-80,097.0000
-99,805.0000
-459,650.0000
-123,124.0000
-50,652.0000
Total Unusual Items Excluding Goodwill
--
--
-299,705.0000
45,416.0000
--
Total Unusual Items
--
--
-299,705.0000
45,416.0000
--
Normalized EBITDA
-50,073.0000
-69,289.0000
182,273.0000
-173,949.0000
-38,565.0000
Tax Rate for Calcs
0.0002
0.0002
0.0000
0.0000
--
Tax Effect of Unusual Items
--
--
-2,397.6400
1,998.3040
--
2/28/2021 - 7/1/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHR Phreesia, Inc.
18.46
-0.05%
PRVA Privia Health Group, Inc.
19.22
+1.21%
SLP Simulations Plus, Inc.
27.49
-1.04%
AMWL American Well Corporation
9.12
+1.33%
DRIO DarioHealth Corp.
0.9200
-2.90%
HQY HealthEquity, Inc.
86.95
+0.72%
EVH Evolent Health, Inc.
23.36
-0.43%
NRC National Research Corporation
18.50
+1.87%
SY So-Young International Inc.
0.8725
+1.32%
BTSG BrightSpring Health Services, Inc.
16.81
-2.55%